PB2408: PREVALENCE OF METABOLIC SYNDROME IN LONG TERM HEMATOPOIETIC STEM CELL TRANSPLANTATION SURVIVORS: COMPARISON WITH A MATCHED REFERENCE COHORT.

por van Yperen, Nicole, van Greevenbroek, M., Wauben, B., van der Poel, M., Schouten, H.
Publicado 2023

MIB-1 labelling index is an independent prognostic marker in primary breast cancer.

por Jansen, R. L., Hupperets, P. S., Arends, J. W., Joosten-Achjanie, S. R., Volovics, A., Schouten, H. C., Hillen, H. F.
Publicado 1998

Successful intergeneric transfer of a major apple scab resistance gene (Rvi6) from apple to pear and precise comparison of the downstream molecular mechanisms of this resistance in...

por Perchepied, L., Chevreau, E., Ravon, E., Gaillard, S., Pelletier, S., Bahut, M., Berthelot, P., Cournol, R., Schouten, H. J., Vergne, E.
Publicado 2021

Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study

por van der Poel, M. W. M., Mulder, W. J., Ossenkoppele, G. J., Maartense, E., Hoogendoorn, M., Wijermans, P., Schouten, H. C.
Publicado 2015

Anthocyanin production as a potential visual selection marker during plant transformation

por Kortstee, A. J., Khan, S. A., Helderman, C., Trindade, L. M., Wu, Y., Visser, R. G. F., Brendolise, C., Allan, A., Schouten, H. J., Jacobsen, E.
Publicado 2011

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer

por Lalisang, R I, Voest, E E, Wils, J A, Nortier, J W, Erdkamp, F L, Hillen, H F, Wals, J, Schouten, H C, Blijham, G H
Publicado 2000

High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

por Deenik, W., van der Holt, B., Verhoef, G. E. G., Schattenberg, A. V. M. B., Verdonck, L. F., Daenen, S. M. G. J., Zachée, P., Westveer, P. H. M., Smit, W. M., Wittebol, S., Schouten, H. C., Löwenberg, B., Ossenkoppele, G. J., Cornelissen, J. J.
Publicado 2006